Response to Pan et al's "Non-melanoma skin cancer in patients with hereditary hemochromatosis: A case-control study"

Rory Barry; Gregg Murray; Karl Hazel; John Ryan; Richard E Watchorn

doi:10.1016/j.jaad.2023.05.078

Response to Pan et al's "Non-melanoma skin cancer in patients with hereditary hemochromatosis: A case-control study"

J Am Acad Dermatol. 2023 Oct;89(4):e167-e168. doi: 10.1016/j.jaad.2023.05.078. Epub 2023 Jun 13.

Authors

Rory Barry¹, Gregg Murray², Karl Hazel³, John Ryan⁴, Richard E Watchorn²

Affiliations

¹ Department of Dermatology, Beaumont Hospital, Dublin, Ireland. Electronic address: [email protected].
² Department of Dermatology, Beaumont Hospital, Dublin, Ireland.
³ Department of Gastroenterology, Beaumont Hospital, Dublin, Ireland.
⁴ Hepatology Unit, Beaumont Hospital, Dublin, Ireland.

PMID: 37315803
DOI: 10.1016/j.jaad.2023.05.078

No abstract available

Keywords: basal cell carcinoma; clinical research; epidemiology; general dermatology; hereditary hemochromatosis; medical dermatology; nonmelanoma skin cancer; squamous cell carcinoma.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Basal Cell*
Case-Control Studies
Hemochromatosis* / complications
Hemochromatosis* / epidemiology
Hemochromatosis* / genetics
Humans
Skin Neoplasms* / epidemiology